CG Invites Co., Ltd. (KOSDAQ:083790)
South Korea · Delayed Price · Currency is KRW 846.00
0.00 (0.00%)
Jul 21, 2026, 3:30 PM KST
CG Invites Market Cap
CG Invites has a market cap or net worth of 65.05 billion as of July 21, 2026. Its market cap has decreased by -52.26% in one year.
Market Cap
65.05B
Enterprise Value
116.73B
Revenue
29.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
846.00
ChartMarket Cap Chart
Since January 6, 2006, CG Invites's market cap has decreased from 137.39B to 65.05B, a decrease of -52.65%. That is a compound annual growth rate of -3.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 65.05B | -43.11% |
| Dec 30, 2025 | 114.34B | -38.17% |
| Dec 30, 2024 | 184.93B | -11.21% |
| Dec 28, 2023 | 208.28B | -13.64% |
| Dec 29, 2022 | 241.17B | -46.50% |
| Dec 30, 2021 | 450.79B | -45.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genexine | 104.15B |
| Vaxcell-Bio Therapeutics | 92.22B |
| MedPacto | 89.63B |
| Amicogen | 82.36B |
| iNtRON Biotechnology | 79.35B |
| ENCell | 72.13B |
| Prestige BioPharma | 62.62B |
| ORIENT BIO | 53.47B |